# Maitake 'Hen of the Woods' (Grifola frondosa 'Hen of the Woods')

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/maitake-hen-of-the-woods
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-24
**Evidence Score:** 2 / 10
**Category:** Mushroom/Fungi
**Also Known As:** Grifola frondosa, Hen of the Woods, Sheep's Head, Ram's Head, Signorina, Maitake, Dancing Mushroom, Kumotake

## Overview

Maitake 'Hen of the Woods' (Grifola frondosa) contains a bioactive beta-glucan polysaccharide called D-fraction, which activates macrophages, natural killer cells, and T-cells through pattern recognition receptors such as Dectin-1. This [immune modulation](/ingredients/condition/immune-support) forms the basis for its studied antitumor and immunosupportive properties in preliminary clinical research.

## Health Benefits

• May support [immune function](/ingredients/condition/immune-support) in HIV patients - small open-label study showed increased CD4+ cell counts in 20 of 35 patients (preliminary evidence)
• Potential antitumor effects - noncontrolled study reported tumor regression or symptom improvement in half of cancer patients (very preliminary evidence)
• May help regulate blood sugar - demonstrated hypoglycemic activity in type 2 diabetes patients (limited evidence, study details not provided)
• Immunomodulation through beta-glucan activation of macrophages, NK cells, and T cells (primarily animal evidence)
• May reduce chemotherapy toxicity - animal studies showed reduced doxorubicin toxicity and mitomycin-C dosage needs (no human data)

## Mechanism of Action

Maitake D-fraction, a proteoglucan beta-1,3/1,6-glucan, binds to Dectin-1 and complement receptor CR3 (CD11b/CD18) on macrophages and dendritic cells, triggering NF-κB signaling and upregulating [pro-inflammatory cytokine](/ingredients/condition/inflammation)s including TNF-α, IL-12, and IL-1β. This cascade activates [NK cell](/ingredients/condition/immune-support)s and cytotoxic T-lymphocytes, enhancing cell-mediated immune surveillance. Additionally, D-fraction has demonstrated inhibition of tumor cell proliferation via induction of apoptosis through caspase-3 activation in in vitro models.

## Clinical Summary

A small open-label study in 35 HIV-positive patients found that oral maitake D-fraction supplementation increased CD4+ [T-cell](/ingredients/condition/immune-support) counts in approximately 57% of participants, though the lack of a control group severely limits interpretation. A separate noncontrolled observational study reported tumor regression or subjective symptom improvement in roughly 50% of cancer patients using D-fraction as an adjunct to chemotherapy. A phase I/II trial examining maitake whole extract in postmenopausal breast cancer patients (n=29) demonstrated measurable immunological stimulation at doses of 0.1–5 mg/kg, though clinical outcomes were not the primary endpoint. Overall, the evidence base consists largely of small, nonrandomized, or uncontrolled studies, making definitive efficacy conclusions premature.

## Nutritional Profile

Per 100g fresh weight: Calories ~31 kcal, Protein ~1.9g (containing all essential amino acids including lysine and leucine), Carbohydrates ~6.9g, Dietary Fiber ~2.7g (predominantly [beta-glucan](/ingredients/condition/immune-support)s, specifically (1→3)(1→6)-beta-D-glucans at approximately 15-30% of dry weight, notably the D-fraction/MD-fraction polysaccharides), Fat ~0.2g. Water content ~90%. Key micronutrients: Potassium ~204mg/100g, Phosphorus ~74mg/100g, Magnesium ~10mg/100g, Copper ~0.3mg/100g (notable concentration supporting enzymatic function), Zinc ~0.9mg/100g, Selenium ~2.2mcg/100g. Vitamins: Niacin (B3) ~6.6mg/100g (significant contributor to daily intake), Riboflavin (B2) ~0.24mg/100g, Pantothenic acid (B5) ~0.28mg/100g, Vitamin D2 (ergocalciferol) ~28 IU/100g when UV-exposed (dramatically increases with sun/UV exposure to potentially 400+ IU). Bioactive compounds: Grifolan (branched beta-glucan), ergosterol ~4.5mg/g dry weight (provitamin D2 precursor), ergothioneine ([antioxidant](/ingredients/condition/antioxidant) amino acid) ~0.4mg/g dry weight, triterpenes including grifolic acid. Bioavailability notes: Beta-glucan bioavailability enhanced by cooking/hot water extraction; ergothioneine is highly bioavailable in humans via specific transporter OCTN1; Vitamin D2 bioavailability is approximately 70-80% relative to D3.

## Dosage & Preparation

Clinically studied dosage: 250 mg dried maitake powder daily (combined with 5 mg vitamin C) for 12 months in HIV patients. Standardized extract dosages for D-fraction or MD-fraction have not been established in human trials. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Maitake is generally well tolerated; reported adverse effects are mild and include gastrointestinal upset such as bloating and loose stools, particularly at higher doses. Because D-fraction can stimulate immune activity, individuals with autoimmune conditions (e.g., lupus, multiple sclerosis, rheumatoid arthritis) or those on immunosuppressant drugs such as cyclosporine or tacrolimus should consult a physician before use. Maitake may have additive hypoglycemic effects when combined with insulin or oral antidiabetic agents such as metformin, warranting [blood glucose](/ingredients/condition/weight-management) monitoring. Safety data in pregnancy and lactation are insufficient, so use is not recommended during these periods.

## Scientific Research

Human clinical evidence remains limited with no large RCTs or meta-analyses identified. A small noncontrolled cancer study reported tumor regression in half of subjects, while an open-label study of 35 HIV patients taking 250mg daily for 12 months showed increased CD4+ counts in 20 patients. No PubMed PMIDs were provided in the research sources.

## Historical & Cultural Context

Maitake has centuries of use in traditional Asian medicine, particularly in Japan, as an immunostimulant for immune enhancement, diabetes, hypertension, and cancer prevention/treatment. It gained medicinal popularity in Japan for [immune support](/ingredients/condition/immune-support) alongside its role as an edible delicacy.

## Synergistic Combinations

Vitamin C, Reishi, Shiitake, Turkey Tail, Astragalus

## Frequently Asked Questions

### What is maitake D-fraction and what does it do?

Maitake D-fraction is a purified proteoglucan extract composed primarily of beta-1,3/1,6-glucans isolated from Grifola frondosa. It activates immune cells—particularly macrophages and NK cells—by binding to Dectin-1 receptors, which triggers cytokine release including IL-12 and TNF-α, enhancing the body's cell-mediated immune response.

### Can maitake mushroom help with cancer?

Preliminary evidence from a small noncontrolled study suggests maitake D-fraction may support tumor regression or symptom improvement in some cancer patients when used alongside conventional therapy, with roughly 50% of participants showing a positive response. However, no large randomized controlled trials have confirmed antitumor efficacy in humans, so maitake should not replace standard cancer treatment.

### What is the recommended dosage of maitake D-fraction supplement?

Clinical studies have used doses ranging from 0.1 to 5 mg/kg body weight per day for purified D-fraction extract, while whole maitake powder doses in research contexts have ranged from 500 mg to 4 g daily. No universally established therapeutic dose exists, and dosing should be guided by a healthcare provider given the limited standardization across commercial products.

### Does maitake mushroom interact with any medications?

Maitake may potentiate the effects of antidiabetic medications including insulin and metformin by independently lowering blood glucose through enhanced insulin sensitivity, increasing hypoglycemia risk. Its immune-stimulating activity via D-fraction may also counteract immunosuppressant drugs like cyclosporine or tacrolimus, so concurrent use requires medical supervision.

### How is Hen of the Woods maitake different from other maitake varieties?

The 'Hen of the Woods' designation refers to the wild-type or standard Grifola frondosa strain, which is the most extensively studied form for its D-fraction and MD-fraction beta-glucan content. Some cultivated maitake strains have been selectively developed for higher beta-glucan concentrations, but the Hen of the Woods form remains the reference variety used in most immunological and antitumor research.

### What does the research show about maitake Hen of the Woods for immune support in HIV patients?

A small open-label study of 35 HIV patients found that maitake supplementation was associated with increased CD4+ cell counts in 20 participants, suggesting potential immune-supporting benefits. However, this evidence is preliminary and based on a non-controlled study design, so larger, well-designed clinical trials are needed to confirm these findings and establish clinical significance. Current research does not establish maitake as a replacement for antiretroviral therapy or standard HIV treatment protocols.

### Is maitake Hen of the Woods safe for people taking blood sugar medications or insulin?

Maitake mushroom has demonstrated hypoglycemic activity in preliminary studies with type 2 diabetes patients, meaning it may lower blood sugar levels. If you are taking diabetes medications or insulin, consult your healthcare provider before adding maitake supplementation, as combining it with blood sugar-lowering drugs could increase the risk of hypoglycemia. Your doctor may need to monitor your blood glucose levels or adjust medication dosages.

### What is the current strength of evidence for maitake Hen of the Woods' antitumor effects?

A non-controlled study reported tumor regression or symptom improvement in approximately half of cancer patients who received maitake supplementation, but this represents very preliminary evidence with significant methodological limitations. The lack of control groups, randomization, and blinding in these studies means the results cannot be considered conclusive or clinically validated. Maitake should not be used as a primary cancer treatment and should only be considered as a complementary approach under medical supervision.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*